Opting for enteric-coated aspirin over the uncoated pills doesn’t appear to have a major impact on the drug’s antiplatelet effects in patients with atherosclerotic CVD, but nor did it offer an edge in ...

Research led by the Ochsner Medical Center, Louisiana, has found no significant differences in effectiveness or safety outcomes between enteric-coated and uncoated aspirin in patients with ...

A recent analysis from the large ADAPTABLE trial published in JAMA Cardiology showed that enteric coating on aspirin does not change effectiveness or safety for patients with cardiovascular disease.

DEAR MAYO CLINIC: I take low-dose aspirin each day to prevent heart trouble, based on my health care provider’s recommendation. Should I take enteric-coated aspirin to protect my stomach? ANSWER: It ...

An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn't make it any safer either, researchers found ...

This was a post hoc analysis of the 2021 open-label randomized ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness) trial that showed no statistical ...

Is there a significant difference between enteric and nonenteric aspirin? —Janne M. Huynh, MD, Bronx, N.Y. Aspirin and other nonsteroidal anti-inflammatory drugs can cause significant gastroduodenal ...

PLx Pharma has won FDA approval for its liquid-filled aspirin capsule Vazalore. The formulation has bettered enteric-coated and immediate-release aspirin in some regards in clinical trials. Aspirin is ...